NASDAQ · Biotechnology

Lisata Therapeutics, Inc. (LSTA) Stock

$1.06 -11.67% NASDAQ: LSTA Healthcare

Valuation

MetricValue
Price$1.06
Market Cap$9.65M
P/E Ratio-0.90
P/B Ratio1.62
P/S Ratio133.86
EPS (TTM)$-1.91
52-Week High$5.07
52-Week Low$0.99
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-113.79%
ROA-132.59%
ROCE-204.32%
Gross Margin98.82%
Operating Margin-101.78%
Net Margin-96.18%
Debt/Equity0.00
Current Ratio6.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$1.0M$0
Operating Profit$-29.0M$-58.0M$-26.0M$-22.0M$-18.0M
Net Profit$-27.0M$-54.0M$-21.0M$-20.0M$-17.0M
EPS$-7.45$-10.47$-2.58$-2.40$-1.91
Op Margin———-2240.9%-10711.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$97.0M$73.0M$55.0M$35.0M$18.0M
Total Liabilities$5.0M$7.0M$7.0M$6.0M$3.0M
Cash$25.0M$32.0M$23.0M$16.0M$16.0M
Borrowings$1.0M$0$0$0$0

Latest News

Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share Proactive · Jun 10, 2026 Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. GlobeNewswire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-21.0M$-20.0M$-19.0M$-16.0M
Investing Cash Flow$-55.0M$29.0M$10.0M$13.0M$15.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$8.0M$8.0M$-10.0M$-6.0M$0
Free Cash Flow$-22.0M$-21.0M$-20.0M$-19.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-0.18
FCF Yield-92.06%
Quick Ratio3.69
Interest Coverage0.00
Return 1Y38.15%
Return 3Y0.54%
Return 5Y-82.24%

Ownership

Insiders Held20.89%
Institutions Held11.43%
Institutions Float Held14.44%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC271,8152026-03-31
Renaissance Technologies, LLC131,7152026-03-31
Deltec Asset Management LLC90,0002026-03-31
Rangeley Capital, LLC75,0002026-03-31
Geode Capital Management, LLC70,8872026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CLGNCollPlant Biotechnologies Ltd. $3.51 -11.59% -0.37 $4.55M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%
ENLVEnlivex Ltd. $0.25 -8.30% 0.03 $4.28M 0.00%
KLTOKlotho Neurosciences, Inc. $0.38 -7.10% -1.13 $20.08M 0.00%

About Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc. is led by CEO David J. Mazzo, employs 26 people, headquartered in US, publicly traded since 1999.

Lisata Therapeutics, Inc. (LSTA) stock trades at $1.06 with a market capitalization of $9.65M. The stock is valued at a price-to-earnings (P/E) ratio of -0.90, price-to-book of 1.62, price-to-sales of 133.86. Over the past 52 weeks the stock has ranged between $0.99 and $5.07, and currently trades 79.1% below its 52-week high.

On profitability, Lisata Therapeutics, Inc. generates a return on equity (ROE) of -113.79%, return on capital employed of -204.32%, an operating margin of -101.78%, a net profit margin of -96.18%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides